Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 22.50
-0.80 (-3.43%)
Last updated: Dec 5, 2025, 2:09 PM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 129.77 million as of December 5, 2025. Its market cap has decreased by -13.07% in one year.
Market Cap
129.77M
Enterprise Value
277.28M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.95
Stock Price
22.50
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 129.77M, a decrease of -46.03%. That is a compound annual growth rate of -14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 134.38M | -7.86% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 265.72B |
| Novartis AG | 205.08B |
| Galderma Group AG | 38.86B |
| Lonza Group AG | 38.51B |
| Alcon | 31.16B |
| Sandoz Group AG | 24.56B |
| Straumann Holding AG | 14.65B |
| Sonova Holding AG | 11.93B |